Polymyalgia rheumatica vs late-onset rheumatoid arthritis

Rheumatology

Volumn 48, Issue 2, 2009, Pages 93-95

  Cutolo, M ^a   Cimmino, M A ^a   Sulli, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOTROPIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HLA DR ANTIGEN; HYDROCORTISONE; HYDROXYPROGESTERONE; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LEFLUNOMIDE; METHOTREXATE; PLACEBO; PRASTERONE SULFATE; PREDNISONE; STEROID 21 MONOOXYGENASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

CLINICAL FEATURE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HORMONE RELEASE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RELAPSE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGE OF ONSET; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GIANT CELL ARTERITIS; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA;

EID: 58749091658     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken294     Document Type: Editorial

References (19)

1. Pease CT, Haugeberg G, Morgan AW, Montague B, Hensor EM, Bhakta BB. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation. J Rheumatol 2005;32:1852-7.
2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica. Best Pract Res Clin Rheumatol 2004;18:705-22.
3. Boiardi L, Salvarani C, Timms JM, Silvestri T, Macchioni PL, di Giovine FS. Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica. Clin Exp Rheumatol 2000;18:675-81.
4. Straub RH, Gluck T, Cutolo M et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology 2000;39:624-31.
5. Cutolo M, Foppiani L, Minuto F. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest 2002;25:19-23.
6. Cutolo M, Straub RH, Foppiani L et al. Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin-6. J Rheumatol 2002;29:748-56.
7. Iwadate H, Takeda I, Kanno T, Kasukawa R. Elderly onset rheumatoid arthritis complicated by polymyalgia rheumatica. Intern Med 2002;41:657-60.
8. Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: A prospective study. Ann Rheum Dis 2001;60:1021-4.
9. Pease C, Haugeberg G, Montague B et al. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5 yr prospective study. Rheumatology 2009;48:123-7.
10. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Makki R, Garcia-Porrua C, Thomson W, Ollier W. Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. J Rheumatol 2001;28:122-5.
11. Cutolo M, Montecucco CM, Cavagna L et al. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006;65:1438-43.
12. Sulli A, Montecucco CM, Caporali R et al. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis. Ann N Y Acad Sci 2006;1069:307-14.
13. Cutolo M, Straub RH. Polymyalgia rheumatica: Evidence for a hypothalamic-pituitary-adrenal axis-driven disease. Clin Exp Rheumatol 2000;18:655-8.
14. Rainey WE, Naville D, Saez JM et al. Transforming growth factor-beta inhibits steroid 17 alpha-hydroxylase cytochrome P-450 expression in ovine adrenocortical cells. Endocrinology 1990;127:1910-5.
15. Cimmino MA, Moggiana G, Montecucco C, Caporali R, Accardo S. Long term treatment of polymyalgia rheumaticawith deflazacort. Ann Rheum Dis 1994;53:331-6.
16. Myklebust G, Gran JT. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients. Scand J Rheumatol 2001;30:260-7.
17. van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 1996;55:218-23.
18. Caporali R, Cimmino MA, Ferraccioli G et al. Prednisone plus methotrexate for polymyalgia rheumatica. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004;141:493-500.
19. Salvarani C, Macchioni PL, Manzini C et al. Infliximab in the treatment of polymyalgia rheumatica: A double-blind, randomized, placebo-controlled study. Ann Intern Med 2007;146:631-9.